Inovio Pharmaceuticals, Inc. (INO) Technology Highlighted in Human Vaccine Journal

QualityStocks would like to highlight Inovio (NYSE AMEX: INO). The company is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses.

In the company’s news yesterday,

Inovio Pharmaceuticals’ new DNA vaccine delivery technology was recently highlighted in a paper published in the scientific journal Human Vaccines.

Inovio’s DNA technology provides enabling capabilities of electroporation without contacting the skin. While the company’s current devices have been proven safe and well-tolerated in humans, Inovio is advancing its research to get maximal device characteristics to conduct mass vaccinations.

The Human Vaccines paper entitled “Piezoelectric permeabilization of mammalian dermal tissue for in vivo DNA delivery leads to enhanced protein expression and increased immunogenicity,” written by Inovio scientists, describes the electroporation method and investigates the use of the method in animal testing.

Dr. J. Joseph Kim, Inovio’s president and CEO, said the Inovio continues to hold strong position in vaccine delivery methods and noted the advantages of the new DNA vaccine device.

“Inovio continues to raise the bar in terms of technological innovation that will further optimize electroporation-based delivery of DNA-based therapeutics and vaccines for patients of all ages. While still enabling levels of vaccine potency that we have observed with our existing electroporation devices, this new contactless delivery method is non-invasive and amenable to the design of devices that are low-cost, portable, and extremely easy to use,” Dr. Kim stated in the press release.

About QualityStocks

QualityStocks, based in Scottsdale, Arizona, is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters into one Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their investor communication efforts and connecting subscribers with companies that have huge potential to succeed in the short and long-term future.

To sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net

Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net

Forward-Looking Statement:

This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.